BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11449403)

  • 1. Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens.
    Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Baldetorp B
    Cytometry; 2001 Jun; 46(3):121-35. PubMed ID: 11449403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
    Bergers E; Baak JP; van Diest PJ; Willig AJ; Los J; Peterse JL; Ruitenberg HM; Schapers RF; Somsen JG; van Beek MW; Bellot SM; Fijnheer J; van Gorp LH
    Mod Pathol; 1997 Aug; 10(8):762-8. PubMed ID: 9267817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry.
    Bergers E; van Diest PJ; Baak JP
    J Clin Pathol; 1996 Nov; 49(11):931-7. PubMed ID: 8944615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
    Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
    J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of DNA ploidy classification on prognosis in breast cancer.
    Joensuu H; Alanen K; Falkmer UG; Klemi P; Nordling S; Remvikos Y; Toikkanen S
    Int J Cancer; 1992 Nov; 52(5):701-6. PubMed ID: 1428229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting.
    Wong SW; Rangan AM; Bilous AM; Boyages J; Gebski V; Benson EM
    Pathology; 1999 May; 31(2):90-4. PubMed ID: 10399161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
    Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
    Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.
    Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Wright S; Baldetorp B
    Clin Lab Med; 2001 Dec; 21(4):875-95, x. PubMed ID: 11770293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group.
    Bergers E; van Diest PJ; Baak JP
    Cancer; 1996 Jun; 77(11):2258-66. PubMed ID: 8635093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometric analysis of DNA ploidy pattern in breast cancer: malignant potential and prognostic implication].
    Hara S; Tomita M
    Nihon Rinsho; 1992 Oct; 50(10):2444-9. PubMed ID: 1447815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
    Winter K; Eidtmann H; Jonat W
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of proliferative activity and ploidy in node-negative breast cancers.
    Silvestrini R; Daidone MG; Del Bino G; Mastore M; Luisi A; Di Fronzo G; Boracchi P
    Ann Oncol; 1993 Mar; 4(3):213-9. PubMed ID: 8471553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.
    Clark GM; Mathieu MC; Owens MA; Dressler LG; Eudey L; Tormey DC; Osborne CK; Gilchrist KW; Mansour EG; Abeloff MD
    J Clin Oncol; 1992 Mar; 10(3):428-32. PubMed ID: 1740681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer.
    Witzig TE; Ingle JN; Cha SS; Schaid DJ; Tabery RL; Wold LE; Grant C; Gonchoroff NJ; Katzmann JA
    Cancer; 1994 Sep; 74(6):1752-61. PubMed ID: 8082078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076).
    Dressler LG; Eudey L; Gray R; Tormey DC; McGuire WL; Gilchrist KW; Clark GM; Osborne CK; Mansour EG; Abeloff MD
    J Natl Cancer Inst Monogr; 1992; (11):167-72. PubMed ID: 1627424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
    Martin G; Halwani F; Shibata H; Meterissian S
    Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.
    Baldetorp B; Fernö M; Fallenius A; Fallenius-Vecchi G; Idvall I; Olsson H; Sigurdsson H; Akerman M; Killander D
    Cytometry; 1992; 13(6):577-85. PubMed ID: 1451590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.